Literature DB >> 4096878

Trabecular bone remodeling and bone balance in hyperthyroidism.

E F Eriksen, L Mosekilde, F Melsen.   

Abstract

In vivo tetracycline double-labeled iliac crest bone biopsies from 15 hyperthyroid patients were used for the reconstruction of curves describing the variation of resorption depth and formation thickness with time. The curves emerging were compared to curves reconstructed from 13 age- and sex-matched normal individuals (mean age 44 years). The median function period for resorptive cells in hyperthyroid patients (16 days) was about one-third the resorptive period in normals (51 days). No significant difference between the osteoclast-, mononuclear-, or preosteoblast-like cell resorption depths could be demonstrated between the two groups. Consequently, the median resorption rate in hyperthyroid patients (3.8 microns/day) was more than 3 times higher than the value in the control group (1.1 micron/day). Median Sigma, was shorter in the hyperthyroid group (109 days) than in the control group (151 days, P less than 0.05), as was the median initial mineralization lag time (5 and 16 days, respectively, P less than 0.01). No significant difference between the measured mean completed wall thickness (mcwT) values in the hyperthyroid groups and the control group could be demonstrated (58.1 and 60.5 micron respectively). Median initial mineralization rate in the hyperthyroid group (1.2 micron3/micron2 per day) was not significantly higher than the value calculated in the control group (0.9 micron3/micron2 per day), but median initial matrix appositional rate in hyperthyroid (4.8 microns3/micron2 per day) was 3 times higher than the value calculated for normals (1.6 micron3/micron2 per day) (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4096878     DOI: 10.1016/8756-3282(85)90218-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  23 in total

Review 1.  Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?

Authors:  F Bogazzi; E Martino; L Bartalena
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

2.  Bone histomorphometry.

Authors:  F Melsen; T Steiniche
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 3.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 4.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

5.  Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?

Authors:  Tina Z Belsing; Charlotte Tofteng; Bente L Langdahl; Peder Charles; Ulla Feldt-Rasmussen
Journal:  Nutr Metab (Lond)       Date:  2010-09-01       Impact factor: 4.169

6.  High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.

Authors:  Y Hwangbo; J H Kim; S W Kim; Y J Park; D J Park; S Y Kim; C S Shin; N H Cho
Journal:  Osteoporos Int       Date:  2015-08-08       Impact factor: 4.507

7.  The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.

Authors:  M Yamamoto; A Markatos; J G Seedor; P Masarachia; M Gentile; G A Rodan; R Balena
Journal:  Calcif Tissue Int       Date:  1993-10       Impact factor: 4.333

8.  Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates.

Authors:  Kenneth C Lasseter; Arturo G Porras; Andrew Denker; Anu Santhanagopal; Anastasia Daifotis
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

9.  Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.

Authors:  G Weber; S Mora; A Bellini; M Bosco; C Prinster; V Siragusa; B di Natale; G Chiumello
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

Review 10.  Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.

Authors:  J H Duncan Bassett; Graham R Williams
Journal:  Endocr Rev       Date:  2016-02-10       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.